Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.

Saved in:
Bibliographic Details
Title: Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.
Authors: Herbst RS; Yale School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, Connecticut. Electronic address: roy.herbst@yale.edu., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Zhou C; Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China., Burotto M; Centro de Investigación Clínica Bradford Hill, Santiago, Chile., Dols MC; Medical Oncology, Málaga Regional University Hospital, IBIMA, Málaga, Spain., Sendur MAN; Ankara Yıldrım Beyazıt University Faculty of Medicine and Ankara Bilkent City Hospital, Ankara, Turkey., Moiseyenko V; Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology) named after 'N.P. Napalkov' (GBUZ 'SPb CRPCstmc(o)' named after N.P. Napalkov), St. Petersburg, Russia., Casarini I; Hospital Bernardo Houssay, Mar del Plata, Argentina., Nishio M; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-Ku, Japan., Hui R; Westmead Hospital and the University of Sydney, Sydney, Australia; Current affiliation: Centre of Cancer Medicine, University of Hong Kong, Hong Kong., Pons-Tostivint E; Nantes University, Centre Hospitalier Universitaire Nantes, Nantes, France., Dudnik J; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka University Medical Center, Beer-Sheva, Israel., Ahmed S; University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom., Okpara CE; Eisai Ltd., Hatfield, United Kingdom., Dutcus C; Eisai Inc., Nutley, New Jersey., Yin L; Merck & Co., Inc., Rahway, New Jersey., Luo Y; Merck & Co., Inc., Rahway, New Jersey., Chirovsky D; Merck & Co., Inc., Rahway, New Jersey., Bhagwati N; Merck & Co., Inc., Rahway, New Jersey., Abreu DR; Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Gran Canaria, Spain.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Sep; Vol. 20 (9), pp. 1302-1314. Date of Electronic Publication: 2025 May 24.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2025.05.016